The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Development of an Accurate Index for Predicting Outcomes of Patients With Acute Liver Failure
Abstract
Background & Aims Patients with acute liver failure (ALF) have high mortality and frequently require liver transplantation (LT); few reliable prognostic markers are available. Levels of M30, a cleavage product of cytokeratin-18 caspase, are significantly increased in serum samples from patients with ALF who die or undergo LT. We developed a prognostic index for ALF based on level of M30 and commonly measured clinical variables (called the ALFSG index), and compared its accuracy with that of the King’s College criteria (KCC) and model for end stage liver disease (MELD). We also validated our model in an independent group of patients with ALF. Methods Serum levels of M30 and M65 antigen (the total cytokeratin-18 fragment, a marker of apoptosis and necrosis) were measured on 3 of the first 4 days following admission of 250 patients with ALF. Logistic regression was used to determine if the following factors, measured on day 1, were associated with LT or death: age, etiology; coma grade; international normalized ratio (INR); serum pH; body mass index; levels of creatinine, bilirubin, phosphorus, arterial ammonia, and lactate; and log10M30 and log10M65. The area under the receiver operating characteristic (AUROC) was calculated for the ALFSG and other indices. Results Coma grade, INR, levels of bilirubin and phosphorus, and log10 M30 value at study entry most accurately identified patients that would require LT or die. The ALFSG index identified these patients with 85.6% sensitivity and 64.7% specificity. Based on comparison of AUROC values, the ALFSG Index (AUROC 0.822) better identified patients most likely to require LT or die than the KCC (AUROC 0.654) or MELD (AUROC 0.704) (P=.0002 and P=.0010, respectively). We validated these findings in a separate group of 250 patients with ALF. Conclusions The ALFSG Index, a combination of clinical markers and measurements of the apoptosis biomarker M30, better predicts outcomes of patients with ALF than the KCC or MELD. ClinicalTrials.gov NCT00518440
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The apoptotic index, which incorporates full‐length serum cytokeratin 18 (CK18) and caspase‐cleaved CK18 levels, may also be more sensitive than serum ALT in detecting liver injury and also be of prognostic value.212,213”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [213]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016
Early indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
Research works printed but not linked: 23
- Lee, 2008, Acute liver failure: summary of a workshop, Hepatology, 47, 1401, 10.1002/hep.22177 · DOI · Paper page
- Simpson, 2009, The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies, Liver Transpl, 15, 600, 10.1002/lt.21681 · DOI
- Shakil, 2000, Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria, Liver Transpl, 6, 163
- Miyake, 2005, New prognostic scoring model for liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure, Transplantation, 80, 930, 10.1097/01.tp.0000173651.39645.35 · DOI
- Schiodt, 2005, Gc-globulin and prognosis in acute liver failure, Liver Transpl, 11, 1223, 10.1002/lt.20437 · DOI
- Bernal, 2002, Blood lactate as an early predictor of oucome in paracetamol-induced acute liver failure: a cohort study, Lancet, 359, 558, 10.1016/S0140-6736(02)07743-7 · DOI · Paper page
- Baquerizo, 2003, Phosphorus ans an early predictive factor in patients with acute liver failure, Transplantation, 75, 2007, 10.1097/01.TP.0000063219.21313.32 · DOI
- Bhatia, 2006, Predictive value of arterial ammonia for complications and outcome in acute liver failure, Gut, 55, 98, 10.1136/gut.2004.061754 · DOI · Paper page
- Schiodt, 2006, Alpha-fetoprotein and prognosis in acute liver failure, Liver Transpl, 12, 1776, 10.1002/lt.20886 · DOI
- Elinav, 2005, The predictive value of admission and follow up factor V and Vii levels in patients with acute hepatitis and coagulopathy, J Hepatol, 42, 82, 10.1016/j.jhep.2004.09.009 · DOI
- Rutherford, 2006, Influence of high body mass index on outcome in acute liver failure, Clin Gastroenterol Hepatol, 4, 1544, 10.1016/j.cgh.2006.07.014 · DOI
- Malhi, 2006, Apoptosis and necrosis in the liver: a tale of two deaths?, Hepatology, 43, S31, 10.1002/hep.21062 · DOI · Paper page
- El-Hassan, 2003, Involvement of mitochondria in acetaminophen-induced apoptosis and hepatic injury: roles of cytochrome c, Bax, Bid, and caspases, Toxicol Appl Pharmacol, 191, 118, 10.1016/S0041-008X(03)00240-0 · DOI
- Song le, 2004, Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus, J Med Virol, 73, 244, 10.1002/jmv.20082 · doi:10.1002/jmv.20082
- Tagami, 2003, Fas-mediated apoptosis in acute alcoholic hepatitis, Hepatogastroenterology, 50, 443
- Strand, 1998, Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis, Nat Med, 4, 588, 10.1038/nm0598-588 · DOI · Paper page
- Bantel, 2004, Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury, Hepatology, 40, 1078, 10.1002/hep.20411 · DOI · Paper page
- Rutherford, 2007, Serum apoptosis markers in acute liver failure: a pilot study, Clin Gastroenterol Hepatol, 5, 1477, 10.1016/j.cgh.2007.08.007 · DOI
- Volkmann, 2008, Caspase activation is associated with spontaneous recovery from ALF, Hepatology, 47, 1624, 10.1002/hep.22237 · DOI
- Bechmann, 2010, Cytokeratin-18 based modification of MELD score improves prediction of spontaneous survival after acute liver injury, J Hepatol, 53, 593, 10.1016/j.jhep.2010.04.029 · DOI · Paper page
- Bechmann, 2008, Apoptosis versus necrosis rate as predictor for ALF following ACM intoxication compared to acute-on-chronic liver failure, Liver Int, 28, 713, 10.1111/j.1478-3231.2007.01566.x · DOI
- Polson, 2008, Assessment of prognosis in acute liver failure, Semin Liver Dis, 28, 218, 10.1055/s-2008-1073121 · doi:10.1055/s-2008-1073121
- Dhiman, 2007, Early indicators of prognosis in fulminant hepatic failure: an assessment of the model for end-stage liver disease (MELD) and King's College Hospital criteria, Liver Transpl, 13, 814, 10.1002/lt.21050 · DOI
Cited by
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
Wendon, J., Cordoba, J., Dhawan, A., Larsen, F. S., Manns, M., Nevens, F., Samuel, D., Simpson, K. J., Yaron, I., & Bernardi, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.003 · Cited by 917
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Self-citationLiver regeneration — mechanisms and models to clinical application
Forbes, S. J., & Newsome, P. N. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.97 · Cited by 411
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Self-citationAcetaminophen hepatotoxicity: an updated review
Lancaster, E. M., Hiatt, J. R., & Zarrinpar, A. (2015) · Archives of Toxicology · doi:10.1007/s00204-014-1432-2 · Cited by 336
Metadata
- Authors
- Rutherford, A., King, L. Y., Hynan, L. S., Vedvyas, C., Lin, W., Lee, W. M., & Chung, R. T.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 143
- Issue
- 5
- Pages
- 1237-1243
- ISSN
- 0016-5085
- Cited by
- 120
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- National Institutes of Health (K24DK078772, K24 DK078772)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development of an Accurate Index for Predicting Outcomes of Patients With Acute Liver Failure. https://app.cochat.ai/papers/10.1053/j.gastro.2012.07.113
- The paper
- Rutherford, A., King, L. Y., Hynan, L. S., Vedvyas, C., Lin, W., Lee, W. M., & Chung, R. T. (2012). Development of an Accurate Index for Predicting Outcomes of Patients With Acute Liver Failure. Gastroenterology. https://doi.org/10.1053/j.gastro.2012.07.113
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.